Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Tarsus Pharmaceuticals TARS stock failing to hold levels Tarsus Pharmaceuticals posts wider than expected EPS loss Digital Realty Trust Inc DLR Posts Robust Q1 2026 FFO and Revenue Beat Amid Strong Data Center Demand The growth trajectory BlackRock Tech BSTZ is on and where it leads Rallies 20260503 METCZ Ramaco management outlines 2029 senior note repayment plans in its latest quarterly earnings release 3M India Declares Special Dividend of 506 Per Share Posts Stellar Q4 FY26 Results Prediction Markets Face State Crackdown Amid Federal Regulatory TugofWar Gaza Flotilla Detainee Allegations Could Impact Israels International Relations and Economic Stability Japans Megabanks Hit Record Profits on Rising Yen Rates But Analysts Caution Growth May Slow Amid Rising Risks Bitcoins Evolution Signals a Paradigm Shift Beyond Pure Speculation Q2 Holdings Leverages Banking Growth and Practical AI Tools Amid Market Reset ON24 Q4 2025 Earnings EPS Surges 151 Above Estimates as Operational Efficiencies Pay Off Upwork Q1 2026 Earnings Strong EPS Beat Drives Positive Investor Sentiment LOGI Q1 2026 Earnings EPS Slightly Beats Estimates Stock Jumps 646 WTFCN Q1 2026 Earnings Preferred Stocks Underlying EPS Surprises to the Upside Capital Bancorp Inc CBNK Q1 2026 Earnings EPS Misses Estimates Amid Challenging Interest Rate Environment GGAL Q1 2026 Earnings EPS Misses Estimates Amid Challenging Argentine Macro Environment Eaton Vance California Municipal Income Trust CEV Edges Higher Amid Steady Demand Eaton Vance California Municipal Income Trust CEV Holds Steady Near Midpoint of Range Centurion Acquisition Corp Warrant ALFUW Drops 20 Key Levels in Focus Odyssey Marine Exploration OMEX Edges Higher as It Tests Key Resistance Zone Gaia Inc GAIA Edges Higher Amid Modest Trading Activity What Phio Pharmaceuticals PHIO is doing that could pay off big later Eye on Rally 20260506 How X4 Pharmaceuticals XFOR is positioning for the next five years Bearish Sentiment 20260508 SBXE SilverBox management lays out targeted growth priorities for upcoming fiscal year in quarterly earnings release The competitive moat visible in Nelnet NNI earnings Nelnet posts 54 EPS miss against analyst estimates What Social SCPQ auditor changes mean for investors SCPQ Latest Quarter Earnings Social has no EPS or revenue data amid growth push